Allopurinol in Acute Coronary Syndrome

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 162 participants.

Also called NCT03745729

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 162 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03745729
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03745729. Randomized; double masking; primary purpose treatment. Start 2019-03-01 (actual); primary completion 2022-07-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Allopurinol in Acute Coronary Syndrome
Condition
Acute Coronary Syndrome
Intervention (Drug)
allopurinol sustained-release capsules
Intervention (Drug)
placebo capsules
Lead sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (class: other)

Record details

Record id
cardio:ct-nct03745729
Content hash
48e6099b9a32100d39b2f948a6023fbcf3bb5c5b4054b2f6dee82913ddbd864b